Fenofibrate

Is the active ingredient. specific formulations may contain additional inactive ingredients like fillers, binders, and coatings which vary by brand and dosage form (e.g., tablets, capsules).

Treatment of hypertriglyceridemia (high levels of triglycerides in the blood)

Treatment of mixed dyslipidemia (high levels of both triglycerides and cholesterol) when diet and other nonpharmacological measures have not been successful

May be used as an adjunct to diet and other lipidlowering therapies to reduce cardiovascular risk in patients with high triglycerides and cholesterol levels.

Adilip 45mg Tab (Fenofibrate) is a fibric acid derivative that activates peroxisome proliferator-activated receptor alpha (PPAR-α). This activation leads to increased breakdown of triglycerides, reduced production of very-low-density lipoproteins (VLDL), and increased levels of high-density lipoproteins (HDL). These actions contribute to lowering triglyceride levels and improving the cholesterol profile.

Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children. Discard any medication past its expiration date.

Dosage varies depending on individual patient needs and physician recommendation. It's crucial to follow your doctor's prescription exactly.

Usually taken once daily with a meal.

Do not crush, chew, or break extended-release formulations.

Always consult your healthcare provider before starting, stopping or altering your medication dosage.

Abdominal pain

Nausea

Diarrhea

Gallstones

Increased risk of bleeding

Elevated liver enzymes

Allergic reactions (rash, itching, swelling)

Alcohol Consumption

Moderate alcohol consumption should be discussed with your doctor, as it can increase the risk of liver damage and interact with the medication.



While Driving or operating Machinery

Fenofibrate may cause drowsiness or dizziness in some individuals. Avoid driving or operating machinery if experiencing these effects.



Pregnant & Breastfeeding Women

Use during pregnancy and breastfeeding is generally not recommended unless the potential benefit outweighs the risks. Consult your doctor.



Children

Safety and efficacy in children have not been fully established.



Kidney

Patients with severe kidney disease may require dosage adjustments or close monitoring.



Liver

Patients with liver disease should be closely monitored for liver function abnormalities.

Your doctor or pharmacist

The FDA drug label for fenofibrate

Reputable medical websites and journals (e.g., PubMed)